NYSE:FSNB Fusion Acquisition Corp. II (FSNB) Stock Price, News & Analysis → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free FSNB Stock Alerts $10.49 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$10.49▼$10.4950-Day Range$10.49▼$10.4952-Week Range$9.52▼$10.75VolumeN/AAverage VolumeN/AMarket Capitalization$655.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Get Fusion Acquisition Corp. II alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Fusion Acquisition Corp. II Stock (NYSE:FSNB)Fusion Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire businesses in the wealth, financial advice, investment, and asset management sectors, as well as FinTech sector. Fusion Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.Read More FSNB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FSNB Stock News HeadlinesMay 6, 2024 | msn.comMarines' New Fusion Center: Accelerating Future Warfare CapabilitiesApril 12, 2024 | markets.businessinsider.comFusion Pharmaceuticals: Market Perform Rating Amid Acquisition and Promising Prostate Cancer Treatment DataMarch 19, 2024 | marketwatch.comAstraZeneca Buys Fusion for Up to $2.4 Bln -- UpdateMarch 19, 2024 | msn.comFusion Pharmaceuticals Is Being Acquired by AstraZeneca in $2.4 Billion Deal. The Stock Is Soaring.March 19, 2024 | msn.comAstraZeneca Buys Fusion for Initial $2 BlnDecember 26, 2023 | msn.comFusion Acquisition to redeem outstanding class A sharesDecember 22, 2023 | markets.businessinsider.comFusion Acquisition Corp. II Announces Redemption of SharesNovember 16, 2023 | markets.businessinsider.comFusion92 Announces Acquisition of TRAK DataNovember 13, 2023 | markets.businessinsider.comDealerOn announces acquisition of fusionZONE Automotive.October 20, 2023 | finance.yahoo.comFusion Acquisition Corp. II Receives Notice from the NYSE Regarding Immediate Suspension in Trading of Securities and Commencement of Delisting ProceedingsOctober 17, 2023 | finance.yahoo.comNYSE to Commence Delisting Proceedings Against Fusion Acquisition Corp. II (FSNB)August 30, 2023 | bizjournals.comHyperloopTT announces plans to go public — againAugust 30, 2023 | seekingalpha.comFusion Acquisition announces letter of intent to merge with Hyperloop Transportation TechnologiesAugust 30, 2023 | finance.yahoo.comHyperloop Transportation Technologies and Fusion Acquisition Corp. II Announce Letter of Intent for a Business CombinationAugust 22, 2023 | wsj.comFusion Acquisition Corp. II Cl AAugust 11, 2023 | finance.yahoo.comMeteora Capital, LLC Reduces Stake in Fusion Acquisition Corp IIJune 23, 2023 | msn.comFusion Pharmaceuticals is Future Pillar of Cancer Treatment: AnalystMay 16, 2023 | finance.yahoo.comFusion Acquisition Corp. II (NYSE:FSNB) is favoured by institutional owners who hold 54% of the companyApril 25, 2023 | msn.comFusion Acquisition receives NYSE notice for non-complianceApril 24, 2023 | finance.yahoo.comFusion Acquisition Corp. II Receives NYSE Notice Regarding Delayed Form 10-K FilingApril 7, 2023 | marketwatch.com8-K: Fusion Acquisition Corp. IIFebruary 12, 2023 | finance.yahoo.comFusion Acquisition Corp. II (FSNB)January 26, 2023 | news.yahoo.comRenaissance Fusion raises $16.4 million to build nuclear fusion technology in EuropeJanuary 16, 2023 | marketwatch.comIndustrial Butt Fusion Machines Market Size 2023 with Presentation Outlook, Horizontal Viewpoint, global ViewDecember 28, 2022 | benzinga.comHigh Fusion Inc. Announces Closing of InvestmentsSee More Headlines Receive FSNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fusion Acquisition Corp. II and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNYSE:FSNB CUSIPN/A CIK1840225 Webwww.fusionacq.com Phone212-763-0169FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.35) per share Price / Book-29.97Miscellaneous Outstanding Shares62,500,000Free Float16,475,000Market Cap$655.63 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. John James (Age 44)CEO & Director Mr. Erik Werner Thoresen (Age 50)CFO & Director Key CompetitorsAres Acquisition Co. IINYSE:AACTNabors Energy Transition Corp. IINASDAQ:NETDRigel Resource AcquisitionNYSE:RRACScreaming Eagle AcquisitionNASDAQ:SCRMChurchill Capital Corp VIINYSE:CVIIView All Competitors FSNB Stock Analysis - Frequently Asked Questions How have FSNB shares performed in 2024? Fusion Acquisition Corp. II's stock was trading at $10.49 at the beginning of the year. Since then, FSNB stock has increased by 0.0% and is now trading at $10.49. View the best growth stocks for 2024 here. How do I buy shares of Fusion Acquisition Corp. II? Shares of FSNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:FSNB) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.